Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07864272

Assessment of Invasive Genetic Testing in Fetuses With Isolated Intrauterine Growth Restriction Diagnosed After 28 Weeks of Gestation at Strasbourg University Hospitals (2016-2023)

Conditions: Isolated Intrauterine Growth Restriction (IUGR)

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 200
Sponsor: University Hospital, Strasbourg, France

Location: Service de Gynécologie et Obstétrique - CHU de Strasbourg - France Strasbourg

Summary

This study evaluates the diagnostic yield of invasive genetic testing in fetuses with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation, in order to better define indications for invasive procedures and improve clinical counseling.

Eligibility Criteria

Inclusion Criteria: * Maternal age ≥ 18 years * Referral after 28 weeks of gestation for estimated fetal weight \< 3rd percentile, isolated condition * Management at Strasbourg University Hospitals between 01/01/2016 and 01/01/2023 * No documented opposition to reuse of medical data for research Exclusion Criteria: * Suspected fetal structural anomaly or infectious cause * Multiple pregnancy * Incomplete genetic workup

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07864272). StuddyBuddy aggregates publicly available trial information.